- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2014-004407-71.
Displaying page 1 of 1.
EudraCT Number: 2014-004407-71 | Sponsor Protocol Number: IB2014-03 | Start Date*: 2015-01-12 | ||||||||||||||||
Sponsor Name:Institut BergoniƩ | ||||||||||||||||||
Full Title: A Phase II study of XL 184 (Cabozantinib) in treating patients with relapsed Osteosarcomas and Ewing Sarcomas. | ||||||||||||||||||
Medical condition: Patients aged 12 years or older with unresectable locally advanced or metastatic osteosarcoma or Ewing sarcoma | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Completed) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
